查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1950475

消化益生菌市场按产品形式、菌株类型、用途、最终用户和分销管道划分，全球预测（2026-2032年）

Gastrointestinal Function Regulating Probiotics Market by Product Form, Strain Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，胃肠功能调节益生菌市场价值将达到 14.2 亿美元，到 2026 年将成长至 15.8 亿美元，到 2032 年将达到 31.5 亿美元，复合年增长率为 12.05%。

关键市场统计数据
基准年 2025 14.2亿美元
预计年份：2026年 15.8亿美元
预测年份 2032 31.5亿美元
复合年增长率 (%) 12.05%

简要概述影响胃肠道益生菌开发和商业化的菌株水平科学、配方要求和战略重点

益生菌旨在调节胃肠道功能，它独特地融合了临床科学、消费者健康和食品技术创新。这些干预措施利用特定的微生物菌株和递送平台来调节宿主微生物群，支持黏膜屏障功能，并影响肠-脑讯号通路。随着对菌株特异性和製剂稳定性研究的深入，从研发和监管事务到市场营销和供应链等相关人员必须通力合作，共同推进证据生成、产品差异化以及在不同人群中的实际应用。

菌株科学和製剂技术的进步以及消费者期望的变化将如何重塑临床可信度和商业化路径

由于菌株鑑定、个人化营养和监管要求的进步，肠道功能调节益生菌领域正在经历变革。高解析度定序和代谢组学分析使研发人员能够超越泛泛的菌株功效宣称，获得针对特异性机制的文献资料，从而支持差异化市场定位。同时，消费者对肠道健康的关注点也从整体健康转向具体的疗效，例如减少抗生素相关性腹泻或缓解大肠激躁症症状，这迫使品牌采用更注重疗效的通讯和临床终点指标。

2025年后的关税环境及其对原物料采购、供应链韧性和商业性定价策略的营运影响

2025年推出的关税政策为跨境原料采购和成品分销带来了新的摩擦，促使製造商和品牌所有者重新评估其供应链结构。部分原料和包装组件关税的提高增加了部分进口商品的到岸成本，迫使采购部门优先考虑供应商多元化和尽可能选择近岸外包。为此，许多相关人员加快了国内供应商的资格认证，并整合货运以降低单位成本上升的风险。同时，物流合作伙伴扩大了保税仓库的使用，并优化了货运整合，以维持利润率。

将产品形态、治疗用途、终端用户需求、通路和菌株选择与整合开发和上市策略联繫起来的实用細項分析

详细的市场区隔分析揭示了产品创新、临床证据和商业性策略需要协调一致的领域。产品形态分为胶囊/锭剂、机能性食品/饮料、液体和粉末。在机能性食品/饮料类别中，饮料进一步细分为乳製品饮料和非乳製品饮料，食品则分为能量棒和点心。这些形态差异指南展示策略、稳定性测试和消费者定位，因为胶囊和粉剂具有便利性和定量服用的优点，而食品/饮料则便于融入日常饮食中。

美洲、欧洲、中东和非洲以及亚太地区的区域监管差异、消费者偏好和分销管道结构如何影响产品设计和商业化选择。

区域趋势持续影响着全球范围内的配方选择、监管应对措施和商业化计划。在美洲，消费者对肠道健康的高度关注以及涵盖直销模式（包括面向消费者的线上销售和成熟的药房网络）的成熟分销渠道，要求企业同时重视临床验证和电商优化。在美洲经营的品牌正透过整合临床可信度和生活方式定位的行销宣传活动，推动成人和儿童市场的普及。

主要企业如何结合菌株独家性、配方创新和全通路伙伴关係，在肠道健康产品领域建立可持续的竞争优势

该领域的主要企业正致力于以菌株独家性、配方技术和分销管道伙伴关係为核心的差异化策略。领先的创新者正投资于菌株特性研究和临床项目，以证明其具有针对性的健康益处；而其他企业则透过稳定粉末、饮料添加剂或偏好的液体形式，在给药方式和消费者体验方面展开竞争。产品开发商与契约製造组织 (CMO) 之间的策略合作在满足特殊生产需求方面发挥着至关重要的作用，尤其对于需要严格品管和低温运输相容性的多菌株混合物而言更是如此。

一项三管齐下的营运策略，旨在帮助领导者整合临床证据、建立稳健的供应链以及针对特定管道的商业化策略，从而扩大其影响力。

为了实现永续价值，产业领导者应优先考虑三项平行措施：证据产生、配方和供应链韧性以及通路专属商业化。首先，投资临床项目，将以患者为中心的明确终点与菌株选择相结合，尽可能优先进行随机对照试验，并利用真实世界数据补充试验证据。其次，致力于优化配方，以提升稳定性、标靶递送和消费者体验，同时实现原材料来源多元化，并选择二级供应商以降低关税和物流风险。第三，针对每个管道量身订做销售模式：数位管道需要以效果为基础的行销和订阅式物流；药局需要专门的标籤和教育；而整合到食品饮料产业则需要与品类合作伙伴共同开发。

采用透明的混合方法调查方法，整合临床文献、监管分析和相关人员访谈，以产生可操作的见解。

这些研究成果综合了同侪审查的临床文献、监管指导文件、专利概况，并访谈了科学、商业和供应链等关键领域的相关人员。资料收集包括与製剂负责人、临床研究人员、采购人员和通路经理进行深入讨论，以验证产品性能、生产限制和上市策略。分析方法结合了定性主题检验和法规结构的交叉综合，以识别菌株选择、製剂方法和商业化模式中可复製的模式。

融合临床严谨性、配方完整性和商业性灵活性，以释放肠道健康解决方案的治疗价值并建立消费者长期信任。

随着产业相关人员将科学严谨性与卓越营运相结合，肠道益生菌有望从一般健康产品转型为以疗效为导向的辅助治疗产品。最有前景的途径在于：明确菌株特性与可衡量的临床终点之间的联繫；开发能够保持活性并满足用户偏好的配方；以及构建兼顾临床可信度和消费者可及性的商业模式。那些实施整合策略，优先考虑标靶证据、永续采购和通路差异化的公司，将更有能力在实现商业性永续性的同时，为消费者带来切实的健康益处。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 消化益生菌市场（依产品类型划分）

  • 胶囊和片剂
  • 机能性食品和饮料
    • 饮料
      • 乳製品饮料
      • 非乳製品饮料
    • 食物
      • 酒吧
      • 小吃
  • 液体
  • 粉末

9. 按菌株类型分類的消化系统益生菌市场

  • 双歧桿菌
  • 乳酸菌
  • 多股

第十章 按应用分類的消化益生菌市场

  • 抗生素相关腹泻
  • 便秘
  • 腹泻
  • 一般消化系统健康
  • 发炎性肠道疾病
  • 大肠激躁症
  • 乳糖不耐症

第十一章 依最终用户分類的消化益生菌市场

  • 成人版
  • 老年人
  • 儿童

12. 消化益生菌市场依通路划分

  • 直销
  • 线上零售
    • 品牌官方网站
    • 电子商务平台
    • 市场
  • 药局
  • 专卖店
    • 健康食品店
    • 天然食品店
  • 超级市场和大卖场

13. 各地区的消化益生菌市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 消化益生菌市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各国胃肠道益生菌市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

16. 美国胃肠道益生菌市场

第十七章：中国益生菌市场及其对消化功能调节的作用

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Amway Corporation
  • Archer-Daniels-Midland Company
  • Bio-K Plus International Inc.
  • BioGaia AB
  • Chr. Hansen Holding A/S
  • Church & Dwight Co., Inc.
  • Danone SA
  • Deerland Probiotics & Enzymes, Inc.
  • DSM-firmenich AG
  • i-Health, Inc.
  • International Flavors & Fragrances Inc.
  • Kerry Group plc
  • Lallemand Inc.
  • Lifeway Foods, Inc.
  • Lonza Group Ltd.
  • Meiji Holdings Co., Ltd.
  • Morinaga Milk Industry Co., Ltd.
  • Nestle SA
  • Novozymes A/S
  • Probi AB
  • Probiotics International Ltd.
  • Reckitt Benckiser Group plc
  • Tata Consumer Products Limited
  • UAS Laboratories, Inc.
  • Winclove Probiotics BV
  • Yakult Honsha Co., Ltd.
Product Code: MRR-4F7A6D4FD88A

The Gastrointestinal Function Regulating Probiotics Market was valued at USD 1.42 billion in 2025 and is projected to grow to USD 1.58 billion in 2026, with a CAGR of 12.05%, reaching USD 3.15 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.42 billion
Estimated Year [2026] USD 1.58 billion
Forecast Year [2032] USD 3.15 billion
CAGR (%) 12.05%

A concise orientation to strain-level science, formulation imperatives, and strategic priorities shaping gastrointestinal probiotic development and commercialization

Probiotics designed to regulate gastrointestinal function occupy a unique intersection of clinical science, consumer health, and food-technology innovation. These interventions harness defined microbial strains and delivery platforms to modulate host microbiota, support mucosal barrier function, and influence gut-brain signaling pathways. As research deepens on strain specificity and formulation stability, stakeholders from R&D and regulatory affairs to marketing and supply chain must align around evidence generation, product differentiation, and real world usability in diverse populations.

Understanding the mechanisms of action-adhesion to intestinal mucosa, competitive exclusion of pathogens, metabolite production such as short-chain fatty acids, and immunomodulation-enables more predictable translation from bench to shelf. Equally important are formulation choices that preserve viability and target delivery, along with rigorous safety characterization for vulnerable cohorts. Taken together, these elements define a strategic landscape where scientific rigor, consumer trust, and operational readiness determine which probiotic solutions will achieve meaningful clinical and commercial traction.

How advances in strain science, formulation technology, and evolving consumer expectations are reshaping clinical credibility and commercial pathways

The landscape for gastrointestinal function regulating probiotics is undergoing transformative shifts driven by advances in strain characterization, personalized nutrition, and regulatory expectations. High-resolution sequencing and metabolomic profiling are enabling developers to move beyond generic strain claims toward documented, mechanism-specific dossiers that support differentiated positioning. Concurrently, consumer interest in gut health is evolving from generic wellness aspirations to targeted outcomes such as relief from antibiotic associated diarrhea or symptom management in irritable bowel syndrome, prompting brands to adopt more outcome-driven messaging and clinical endpoints.

At the same time, formulation innovation is reshaping route-to-market possibilities. Encapsulation technologies, stabilized powders, and novel food matrices are enabling delivery in capsules and tablets, liquids, and increasingly in functional food and beverage formats that meet consumer preferences for convenience and clean label. Digital channels are accelerating product discovery and repeat purchase, while professional channels such as pharmacies and specialty health stores continue to influence clinical credibility. Together, these shifts require integrated strategies that combine robust clinical evidence, targeted communication, and supply chain agility to capture evolving demand.

The post-2025 tariff environment and its operational consequences for ingredient sourcing, supply chain resilience, and commercial pricing strategies

Tariff policies in 2025 introduced renewed friction for cross-border ingredient sourcing and finished goods movement, prompting manufacturers and brand owners to reassess supply chain configurations. Increased duties on select raw materials and packaging components have elevated landed costs for certain imports, driving procurement teams to prioritize supplier diversification and nearshoring where feasible. In response, many stakeholders accelerated qualification of domestic suppliers and consolidated shipments to mitigate per-unit cost increases, while logistics partners expanded use of bonded warehousing and optimized freight consolidation to preserve margin.

These tariff-related pressures also influenced product assortment decisions and pricing strategies. Some companies rebalanced their portfolios to emphasize locally sourced formulations or finished goods that are less sensitive to import duties, whereas others restructured commercial promotions to offset short-term cost inflation. Importantly, the tariff environment intensified dialogue between regulatory, procurement, and commercial teams to ensure compliance while maintaining market access. Effective post-2025 approaches blend contractual hedging, strategic inventory, and transparent consumer communication about quality and origin to sustain trust and protect margins.

Actionable segmentation insights linking product formats, therapeutic applications, end-user needs, distribution pathways, and strain choices into cohesive development and go-to-market strategies

A granular segmentation lens reveals where product innovation, clinical evidence, and commercial tactics must align. Product form spans Capsules & Tablets, Functional Food & Beverages, Liquid, and Powder; within Functional Food & Beverages, opportunities bifurcate into Beverages and Food, with Beverages further distinguished as Dairy Based Beverages and Non Dairy Beverages, and Food encompassing Bars and Snacks. These form distinctions guide shelf strategy, stability testing, and consumer positioning, as capsules and powders address convenience and measured dosing while foods and beverages enable integration into daily diets.

Application segmentation covers indications such as Antibiotic Associated Diarrhea, Constipation, Diarrhea, General Digestive Health, Inflammatory Bowel Disease, Irritable Bowel Syndrome, and Lactose Intolerance, each demanding different clinical endpoints, safety considerations, and regulatory messaging. End users include Adult, Geriatric, and Pediatric populations, and each cohort imposes distinct formulation and labeling constraints; for example, pediatric products must account for taste masking and dosing simplicity, while geriatric offerings prioritize swallowability and comorbidity profiles. Distribution channels range from Direct Sales, Online Retail, Pharmacy, Specialty Stores, and Supermarket & Hypermarket; the Online Retail channel further divides into Brand Websites, E Commerce Platforms, and Marketplaces, while Specialty Stores include Health Food Stores and Natural Product Stores. Finally, strain type segmentation spans Bifidobacterium, Lactobacillus, and Multi Strain approaches, each with unique evidence expectations and manufacturing controls. Integrating these segmentation axes enables targeted product development pathways, regulatory strategies, and channel plans that match consumer needs with operational capabilities.

How regional regulatory nuances, consumer preferences, and channel structures in the Americas, EMEA, and Asia-Pacific inform product design and commercialization choices

Regional dynamics continue to shape formulation choices, regulatory navigation, and commercialization plans across the globe. In the Americas, consumer awareness of gut health is high and channel sophistication spans direct-to-consumer digital sales to well established pharmacy networks, prompting a dual focus on clinically substantiated claims and e-commerce optimization. Brands operating in the Americas benefit from integrated marketing campaigns that combine clinical credibility with lifestyle positioning to drive adoption across adult and pediatric segments.

Europe, Middle East & Africa present a more fragmented regulatory and reimbursement environment, with varying expectations for health claims and differing professional endorsement dynamics. This region rewards rigorous clinical documentation and close engagement with regulatory authorities, while localized flavor and product safety requirements influence formulation decisions. In the Asia-Pacific region, rapid urbanization and rising disposable incomes are driving demand for convenient functional foods and beverages, supported by strong retail ecosystems and growing online marketplaces. However, Asia-Pacific also requires careful navigation of local consumer preferences, ingredient sourcing norms, and regulatory pathways, necessitating flexible product design and culturally informed marketing.

How leading companies combine strain exclusivity, formulation innovation, and omnichannel partnerships to build durable competitive differentiation in gut health products

Key companies in this space pursue differentiated strategies centered on strain exclusivity, formulation technology, and channel partnerships. Leading innovators invest in strain characterization and clinical programs that substantiate targeted health outcomes, while others compete on delivery formats and consumer experience through stabilized powders, beverage integrations, or palatable liquid formats. Strategic collaborations between product developers and contract manufacturing organizations have become central to scaling specialized production demands, especially for multi strain blends that require rigorous quality control and cold chain considerations.

In parallel, commercial leaders are refining omnichannel distribution models that connect digital performance marketing with professional endorsement and pharmacy presence, enabling both rapid trial and sustained adherence. Companies that effectively integrate evidence generation with supply chain reliability and clear professional engagement are better positioned to influence formulary choices and consumer loyalty. Finally, nimble mid-sized companies often exploit niche indications or population segments to establish footholds that can later be expanded, underscoring the value of focused clinical programs and targeted channel deployment.

A three-track operational playbook for leaders to align clinical evidence, resilient supply chains, and channel-specific commercialization to scale impact

Industry leaders should prioritize three parallel tracks to capture durable value: evidence generation, formulation and supply chain resilience, and channel-specific commercialization. First, invest in clinical programs that align strain selection with clear, patient-centric endpoints; prioritize randomized, controlled studies where feasible and leverage real world data to complement trial evidence. Second, optimize formulations for stability, targeted delivery, and consumer experience, while diversifying ingredient sources and qualifying secondary suppliers to reduce tariff and logistics exposure. Third, tailor commercialization models by channel: digital channels require performance marketing and subscription logistics, pharmacies demand professional labeling and educational outreach, and food and beverage integrations necessitate co-creation with category partners.

Implementation should proceed through phased initiatives that allow rapid learning. Start with pilot clinical studies tied to a single form factor and indication, then extend successful formulations into adjacent formats and channels. Build strategic manufacturing partnerships that offer scalability and quality control, and invest in data systems that connect consumer feedback, adherence metrics, and adverse event monitoring. By executing these integrated actions, leaders can turn scientific differentiation into sustained market preference and operational resilience.

A transparent mixed-methods research approach integrating clinical literature, regulatory analysis, and stakeholder interviews to produce actionable insights

The research behind these insights synthesizes peer-reviewed clinical literature, regulatory guidance documents, patent landscapes, and primary stakeholder interviews across scientific, commercial, and supply chain functions. Data collection included in-depth discussions with formulators, clinical investigators, procurement leads, and channel managers to triangulate product performance, manufacturing constraints, and go-to-market practices. Analytical methods combined qualitative thematic analysis with cross-cutting synthesis of regulatory frameworks to identify reproducible patterns in strain selection, formulation approaches, and commercialization models.

Quality assurance included independent verification of clinical study designs and endpoints, review of stability data where available, and confirmation of distribution channel behaviors through retailer and platform observations. The methodology emphasizes transparency, replicability, and pragmatic relevance, enabling decision-makers to translate the findings into prioritized action items and further investigative questions tailored to specific organizational needs.

Converging clinical rigor, formulation integrity, and commercial agility to unlock therapeutic value and long-term consumer trust in gut health solutions

Gastrointestinal function regulating probiotics are poised to move from general wellness products to outcome-driven therapeutic adjuncts when industry actors align scientific rigor with operational excellence. The most promising pathways involve clear linkage of strain identity to measurable clinical endpoints, formulations that preserve viability and meet user preferences, and commercial models that bridge clinical credibility with consumer accessibility. Firms that execute integrated strategies-prioritizing targeted evidence, resilient sourcing, and channel differentiation-will be best positioned to deliver meaningful health benefits while achieving commercial sustainability.

Moving forward, continued investment in high-quality clinical trials, pragmatic real world evidence collection, and flexible manufacturing partnerships will be essential. By focusing on these priorities, stakeholders can reduce translational risk, increase consumer trust, and unlock new applications for probiotics in managing defined gastrointestinal conditions and supporting everyday digestive health.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gastrointestinal Function Regulating Probiotics Market, by Product Form

  • 8.1. Capsules & Tablets
  • 8.2. Functional Food & Beverages
    • 8.2.1. Beverages
      • 8.2.1.1. Dairy Based Beverages
      • 8.2.1.2. Non Dairy Beverages
    • 8.2.2. Food
      • 8.2.2.1. Bars
      • 8.2.2.2. Snacks
  • 8.3. Liquid
  • 8.4. Powder

9. Gastrointestinal Function Regulating Probiotics Market, by Strain Type

  • 9.1. Bifidobacterium
  • 9.2. Lactobacillus
  • 9.3. Multi Strain

10. Gastrointestinal Function Regulating Probiotics Market, by Application

  • 10.1. Antibiotic Associated Diarrhea
  • 10.2. Constipation
  • 10.3. Diarrhea
  • 10.4. General Digestive Health
  • 10.5. Inflammatory Bowel Disease
  • 10.6. Irritable Bowel Syndrome
  • 10.7. Lactose Intolerance

11. Gastrointestinal Function Regulating Probiotics Market, by End User

  • 11.1. Adult
  • 11.2. Geriatric
  • 11.3. Pediatric

12. Gastrointestinal Function Regulating Probiotics Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Online Retail
    • 12.2.1. Brand Websites
    • 12.2.2. E Commerce Platforms
    • 12.2.3. Marketplaces
  • 12.3. Pharmacy
  • 12.4. Specialty Stores
    • 12.4.1. Health Food Stores
    • 12.4.2. Natural Product Stores
  • 12.5. Supermarket & Hypermarket

13. Gastrointestinal Function Regulating Probiotics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Gastrointestinal Function Regulating Probiotics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Gastrointestinal Function Regulating Probiotics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Gastrointestinal Function Regulating Probiotics Market

17. China Gastrointestinal Function Regulating Probiotics Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Amway Corporation
  • 18.6. Archer-Daniels-Midland Company
  • 18.7. Bio-K Plus International Inc.
  • 18.8. BioGaia AB
  • 18.9. Chr. Hansen Holding A/S
  • 18.10. Church & Dwight Co., Inc.
  • 18.11. Danone S.A.
  • 18.12. Deerland Probiotics & Enzymes, Inc.
  • 18.13. DSM-firmenich AG
  • 18.14. i-Health, Inc.
  • 18.15. International Flavors & Fragrances Inc.
  • 18.16. Kerry Group plc
  • 18.17. Lallemand Inc.
  • 18.18. Lifeway Foods, Inc.
  • 18.19. Lonza Group Ltd.
  • 18.20. Meiji Holdings Co., Ltd.
  • 18.21. Morinaga Milk Industry Co., Ltd.
  • 18.22. Nestle S.A.
  • 18.23. Novozymes A/S
  • 18.24. Probi AB
  • 18.25. Probiotics International Ltd.
  • 18.26. Reckitt Benckiser Group plc
  • 18.27. Tata Consumer Products Limited
  • 18.28. UAS Laboratories, Inc.
  • 18.29. Winclove Probiotics B.V.
  • 18.30. Yakult Honsha Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY CAPSULES & TABLETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY CAPSULES & TABLETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY CAPSULES & TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DAIRY BASED BEVERAGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DAIRY BASED BEVERAGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DAIRY BASED BEVERAGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY NON DAIRY BEVERAGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY NON DAIRY BEVERAGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY NON DAIRY BEVERAGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BARS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BARS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BARS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SNACKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SNACKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SNACKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BIFIDOBACTERIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BIFIDOBACTERIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BIFIDOBACTERIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY LACTOBACILLUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY LACTOBACILLUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY LACTOBACILLUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY MULTI STRAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY MULTI STRAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY MULTI STRAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ANTIBIOTIC ASSOCIATED DIARRHEA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ANTIBIOTIC ASSOCIATED DIARRHEA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ANTIBIOTIC ASSOCIATED DIARRHEA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY CONSTIPATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY CONSTIPATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY CONSTIPATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DIARRHEA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DIARRHEA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DIARRHEA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY GENERAL DIGESTIVE HEALTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY GENERAL DIGESTIVE HEALTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY GENERAL DIGESTIVE HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY IRRITABLE BOWEL SYNDROME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY IRRITABLE BOWEL SYNDROME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY IRRITABLE BOWEL SYNDROME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY LACTOSE INTOLERANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY LACTOSE INTOLERANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY LACTOSE INTOLERANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BRAND WEBSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BRAND WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BRAND WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY E COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY E COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY MARKETPLACES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY MARKETPLACES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY MARKETPLACES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY HEALTH FOOD STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY HEALTH FOOD STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY HEALTH FOOD STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY NATURAL PRODUCT STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY NATURAL PRODUCT STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY NATURAL PRODUCT STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SUPERMARKET & HYPERMARKET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SUPERMARKET & HYPERMARKET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SUPERMARKET & HYPERMARKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 212. GCC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. GCC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 214. GCC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 215. GCC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 216. GCC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, 2018-2032 (USD MILLION)
  • TABLE 217. GCC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. GCC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. GCC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. GCC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 221. GCC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 222. GCC GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 245. G7 GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. G7 GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 247. G7 GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 248. G7 GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 249. G7 GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FOOD, 2018-2032 (USD MILLION)
  • TABLE 250. G7 GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY STRAIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. G7 GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. G7 GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. G7 GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 254. G7 GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 255. G7 GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY SPECIALTY STORES, 2018-2032 (USD MILLION)
  • TABLE 256. NATO GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 257. NATO GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
  • TABLE 258. NATO GASTROINTESTINAL FUNCTION REGULATING PROBIOTICS MARKET SIZE, BY FUNCTIONAL F